Supplementary protection
LT - (S)-2-(((S)-6,8-difluor-1,2,3,4-tetrahidronaftalen-2-il)amino)-N-(1-(2-metil-1-(neopentilamino)propan-2-il)-1H-imidazol-4-il)pentanamido kieto pavidalo formos ir jų panaudojimas
EN - SOLID STATE FORMS OF (S)-2-(((S)-6,8-DIFLUORO-1,2,3,4-TETRAHYDRONAPHTHALEN-2-YL)AMINO)-N-(1-(2-METHYL-1-(NEOPENTYLAMINO)PROPAN-2-YL)-1H-IMIDAZOL-4-YL)PENTANAMIDE AND USES THEREOF
SPC
| (11) |
Number of the document |
|
| (68) |
Number of the document |
4010322
|
| (21) |
Application number for Supplementary Protection Certificate |
PA 2026 516 |
| (22) |
Date of filing the application |
2026-04-23 |
| (41) |
Date of publication of the application |
2026-05-11 |
|
Date of publication of SPC |
|
| (24) |
Date of coming into effect of SPC |
|
Applicant
| (71) |
Pfizer Inc. ,
66 Hudson Boulevard East, New York, NY 10001-2192,
US
|
Grantee
| (73) |
Pfizer Inc. ,
66 Hudson Boulevard East, New York, NY 10001-2192,
US
|
Attorney or representative
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
| (93) |
EU/1/25/1932, 2025-08-14
|
Name of the product protected by the basic patent
| (95) |
Ogsiveo - nirogacestatas |
Legal status
|
SPC application published
|
|
